白血病相关抑制物对正常人T淋巴细胞集落形成的影响

通过收集16例急性非淋巴细胞白血病(ANLL)病人的血清和外周血白血病细胞条件培养液(LCM),对血清和LCM中的白血病相关抑制物(LAI)对正常人T淋巴细胞集落(CFU-TL)形成的影响进行研究。发现16例病人的LAI对正常人CFU-TL均有抑制作用,而缓解期病人的LAI抑制作用甚弱。追踪观察11例病人:其中抑制率高于30％的6例患者治疗效果差;抑制率低于25％的5例患者治疗效果较好,达到完全缓解或部分缓解。结果提示ANLL病人的细胞免疫功能缺陷与LAI的存在有关。     

儿童急性白血病诊治初探

目的：探讨儿童急性白血病转归与治疗的关系。方法；对接受治疗的患儿进行疗效观察，比较。结果：接受正规化疗者骨髓持续完全缓解率[CCR]高，不正规化疗者出现并发症，预后差。结论：正规长期化疗与长期生存呈正相关关系。     

As2O3联合小剂量化疗治疗急性早幼粒细胞白血病的临床研究

探讨治疗急性早幼粒细胞白血病（APL）更有效的方法，以延长患者的生存期，提高生活质量。采用As2O3注射液10mg/d加入10％葡萄注射液250－500mL静脉滴注，连续28d一个疗程；同时用可糖胞苷50－100mg或高三尖杉酯碱1－2mg加入10％葡萄糖注射250mL静脉滴注，7－10d为1疗程，观察其临床症状、血象及骨髓象的变化，并追踪观察其缓解率及生存期。结果表明，采用A2sO3注射液加小剂量化疗的方法治疗APL，有明显的疗效，能够有效控制APL病情，提高完全缓解率，减少白血病的复发率与患者死亡率。     

Knockdown of <Emphasis Type="Italic">MRP4</Emphasis> by lentivirus-mediated siRNA improves sensitivity to adriamycin in adriamycin-resistant acute myeloid leukemia cells

Chemotherapy remains the standard treatment for acute myeloid leukemia;however,the emergence of drug resistance is a major hurdle in the successful treatment of leukemia.The expression of multidrug resistance-associated protein 4(MRP4)induces re- sistance in the adriamycin-resistant acute myeloid leukemia cell line,K562/ADR.The aim of this study was to investigate whether knockdown of MRP4 by lentivirus-mediated siRNA could improve the sensitivity of K562/ADR cells to adriamycin.Five lenti- virus-mediated short hairpin RNAs(lv-shRNAs-MRP4)were designed to trigger the gene silencing RNA interference(RNAi) pathway.The efficiency of lentivirus-mediated siRNA infection into K562/ADR cells was determined using fluorescence mi- croscopy to observe lentivirus-mediated GFP expression.MRP4 expression in infected K562/ADR cells was evaluated by real- time PCR and Western blot analysis.The MTS assay was used to measure cell viability and flow cytometry was used to measure apoptosis.The transfection efficiency of K562/ADR cells was over 80 percent.The gene silencing efficacy of lv-shRNA1-MRP4 was superior to the other constructs.Infection of K562/ADR cells with lv-shRNA1-MRP4 led to strong inhibition of MRP4 mRNA and protein expression.Combined treatment with lv-shRNA1-MRP4 and adriamycin decreased cell growth and increased apoptosis compared to treatment with lv-shRNA1-MRP4 or adriamycin alone.These data indicate that in K562/ADR cells MRP4 is involved in drug resistance mechanisms and that lentivirus-mediated knockdown of MRP4 may enhance sensitivity to adriamycin.     

白血病G6PD蛋白表达的研究

目的:观察白血病患者骨髓中白血病细胞葡萄糖-6磷酸脱氢酶(G6PD)蛋白的表达情况,探讨G6PD与白血病的关系。方法:应用免疫组化方法检测35例白血病患者和35例非恶性血液病患者骨髓组织标本中白血病细胞G6PD蛋白的表达,比较白血病患者和非恶性血液病患者G6PD蛋白表达率的差异。结果:G6PD蛋白在白血病骨髓组织白血病细胞中呈现弱阳性表达。35例白血病患者骨髓组织中G6PD蛋白阳性表达率为25.7%(9/35),而35例非恶性血液病患者骨髓组织中G6PD蛋白阳性表达率为2.9%(1/35),差异有统计学意义(P<0.05)。结论:白血病可能存在G6PD蛋白的表达上调,值得进一步研究。     

鬼臼乙叉甙诱导NB4细胞凋亡的实验研究

为了从细胞凋亡角度探讨鬼臼乙叉甙（4′－demethylepipodophyllotoxin-9-4(4,6-O-ethylidene-β－D－glucopyranoside）抗肿瘤作用的机理。用活细胞计数法,克隆形成法及MTT比色法观察了其对NB4细胞的生长抑制作用;用光学显微镜及电子显微镜观察了凋亡细胞的形态学变化;用琼脂糖凝胶电泳观察了DNA的梯形改变。结果发现：鬼臼乙叉甙能显著抑制NB4细胞的生长增殖及诱导其凋亡,诱导凋亡是鬼臼乙叉甙抗肿瘤作用的机理之一。     

新近发现的恶性肿瘤的染色体异常

作者报告一组新近发现的恶性肿瘤的染色体异常,均属少见的染色体变异.系采用淋巴结或骨髓直接法制备染色体标本.恶性淋巴瘤核型为14q~+t(2;14);慢性粒细胞白血病核型为pht(2;22).讨论了癌基因与染色体易位的关系.     

Antiproliferative effects of 4′, 5′-unsaturated adenine nucleosides on leukemia L 1210 cells in vitro

Summary Several 4, 5-unsaturated adenine nucleosides were shown to have antiproliferative activity against L 1210 leukemia cells in vitro. The active nucleosides were cytotoxic to the L 1210 cells as demonstrated by Trypan Blue uptake. The cytotoxicity was not induced by alterations in the ribonucleoside and deoxyribonucleoside triphosphate levels of the L 1210 cells.